PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases (pealkiri)

teaviku laadid

Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Kirjeid leitud 1, kuvan 1 - 1